Orexigen Therapeutics (Comparative Multiple Analysis)
Improve your investment analysis with by seeing the Orexigen Therapeutics's Discounted Cash Flow analysis, Orexigen Therapeutics's Warren Buffet analysis, and Orexigen Therapeutics's Weighted Average Cost of Capital (WACC) Analysis.
Notes on the Comparative Multiple Analysis of Orexigen Therapeutics
WikiWealth compares Orexigen Therapeutics's revenue, EBITDA, and EBIT multiples to their peers in order to determine the appropriate fair valuation. Click in the top right corner to experiment with Orexigen Therapeutics's comparative analysis.
Notes from the analysis:
1. WikiWealth uses quantitative measures to determine the multiple range for Orexigen Therapeutics.
Helpful Information for Orexigen Therapeutics's Analysis
How does this work? The Comparative Investment Analysis determines the value of Orexigen Therapeutics by comparing Orexigen Therapeutics financial ratios, prices, growth rates, margins, etc. to those of relevant peer groups.
Value Investing Importance? This method is widely used by investment professionals to determine the correct price of investments, especially initial public offerings (IPOs). It is one element of WikiWealth's three Wall Street approaches used to determine the correct fair value of Orexigen Therapeutics.
Also, see the Orexigen Therapeutics's buffett intrinsic valuation analysis for WikiWealth's attempt to replicate the investing formula's used by Warren Buffett and Orexigen Therapeutics's valuation conclusion for a quick summary.